Brihad Abhyankar
Technik-/Wissenschafts-/F&E-Leiter bei MORPHIC HOLDING, INC.
Profil
Brihad Abhyankar is currently working as the Vice President of Clinical Development at Morphic Holding, Inc. and Morphic Therapeutic, Inc. He previously worked as the Medical Director of Clinical Sciences at Takeda Pharmaceuticals Europe Ltd.
from 2012 to 2015, as the Medical Director at Theravance Biopharma US, Inc. from 2017 to 2022, and as the Head of Clinical Development at Akari Therapeutics Plc in 2016.
He completed his undergraduate and graduate studies at the University of Mumbai and holds an MBA from Henley Management College.
Aktive Positionen von Brihad Abhyankar
| Unternehmen | Position | Beginn |
|---|---|---|
| MORPHIC HOLDING, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.04.2022 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
Ehemalige bekannte Positionen von Brihad Abhyankar
| Unternehmen | Position | Ende |
|---|---|---|
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2022 |
| AKARI THERAPEUTICS, PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2017 |
Takeda Pharmaceuticals Europe Ltd.
 Takeda Pharmaceuticals Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals Europe Ltd. provides management services. The company is based in Westminster, UK. The CEO of the British company is Trevor Smith. | Corporate Officer/Principal | 01.04.2015 |
Ausbildung von Brihad Abhyankar
| Henley Management College | Masters Business Admin |
| University of Mumbai | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| AKARI THERAPEUTICS, PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
Takeda Pharmaceuticals Europe Ltd.
Takeda Pharmaceuticals Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals Europe Ltd. provides management services. The company is based in Westminster, UK. The CEO of the British company is Trevor Smith. | Commercial Services |
